glucagon has been researched along with pyrroles in 18 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (pyrroles) | Trials (pyrroles) | Recent Studies (post-2010) (pyrroles) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 26,129 | 2,815 | 12,100 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 12 (66.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Absood, A; Maruno, K; Said, SI | 1 |
| Berlin, I; Blacker, C; Cesselin, F; Chalon, S; Fuseau, E; Landault, C; Puech, AJ; Rosenzweig, P | 1 |
| Deacon, CF; Holst, JJ; Hughes, TE | 1 |
| Ber, E; Cascieri, MA; Chicchi, GG; de Laszlo, SE; Hacker, C; Hagmann, WK; Koch, GE; Louizides, D; MacCoss, M; Sadowski, SJ; Vicario, PP | 1 |
| Asano, O; Ikuta, H; Nagakura, T; Tanaka, I; Yamazaki, K; Yasuda, N; Yoshikawa, S | 1 |
| Alpern, RJ; Amemiya, M; Ando, Y; Asano, Y; Kusano, E; Muto, S; Tabei, K | 1 |
| Dallas-Yang, Q; Jiang, G; Qureshi, SA; Xie, D; Zhang, BB | 1 |
| Deacon, CF; Holst, JJ; Møller, S; Plamboeck, A | 1 |
| Inoue, T; Kira, K; Nagakura, T; Saeki, T; Tanaka, I; Yamazaki, K; Yasuda, N | 1 |
| Aguilar-Bryan, L; Bryan, J; Crane, A; Hu, M; Nakazaki, M; Seghers, V; Ullrich, S | 1 |
| Ikuta, H; Nagakura, T; Tanaka, I; Yamazaki, K; Yasuda, N | 1 |
| Deacon, CF; Holst, JJ; Kelstrup, M; Klarskov, L; Olesen, M; Trebbien, R | 1 |
| Philips, JC; Radermecker, RP; Scheen, AJ | 1 |
| Ahrén, B; Hughes, TE | 1 |
| de Heer, J; Deacon, CF; Holst, JJ; Plamboeck, A; Rosenkilde, MM | 1 |
| Chen, XQ; Dong, J; Du, JZ; Fan, JM; Niu, CY | 1 |
| Chen, CR; Kodra, JT; Liu, X; Yu, R | 1 |
| Hernández-Cascales, J; Merino, B; Quesada, I | 1 |
1 trial(s) available for glucagon and pyrroles
| Article | Year |
|---|---|
Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Glipizide; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Indoles; Insulin; Male; Pyrroles; Reference Values | 1994 |
17 other study(ies) available for glucagon and pyrroles
| Article | Year |
|---|---|
VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Carbazoles; Cell Cycle; Cell Division; Cell Line; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; DNA; Dose-Response Relationship, Drug; Glucagon; Histamine; Histamine Antagonists; Humans; Indoles; Kinetics; Muscle, Smooth; Pyrroles; Thymidine; Trachea; Vasoactive Intestinal Peptide | 1995 |
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.
Topics: Anesthetics; Animals; Dipeptidyl Peptidase 4; Drug Evaluation, Preclinical; Drug Synergism; Glucagon; Glucagon-Like Peptide 1; Glucose; Homeostasis; Infusions, Intravenous; Insulin; Insulin Secretion; Peptide Fragments; Protein Precursors; Pyrroles; Secretory Rate; Swine; Valine | 1998 |
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor.
Topics: Adenylyl Cyclases; Animals; Cations, Divalent; CHO Cells; Cricetinae; Enzyme Activation; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Hormone Antagonists; Humans; Molecular Structure; Mutation; Peptides; Protein Binding; Pyridines; Pyrroles; Receptors, Glucagon | 1999 |
Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient Fischer rats.
Topics: Animals; Blood Glucose; Dipeptidyl Peptidase 4; Duodenum; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Insulin; Insulin Secretion; Intubation, Gastrointestinal; Male; Peptide Fragments; Protein Precursors; Pyrroles; Rats; Rats, Inbred F344; Rats, Mutant Strains; Species Specificity; Valine | 2001 |
Glucagon acutely inhibits but chronically activates Na(+)/H(+) antiporter 3 activity in OKP cells.
Topics: Animals; Biological Transport; Carbazoles; Cell Line; Cell Membrane; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Female; Glucagon; Hydrogen-Ion Concentration; Indoles; Kidney; Opossums; Pyrroles; RNA, Messenger; Sodium; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers | 2002 |
Detection of glucagon-dependent GTPgammaS binding in high-throughput format.
Topics: Animals; Binding Sites; Cell Membrane; CHO Cells; Cricetinae; Glucagon; Guanosine 5'-O-(3-Thiotriphosphate); Heterotrimeric GTP-Binding Proteins; Humans; Isotope Labeling; Pyridines; Pyrroles; Receptors, Glucagon; Sulfur Radioisotopes | 2002 |
GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion.
Topics: Anesthesia; Animals; Blood Glucose; Chloralose; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Metabolic Clearance Rate; Peptide Fragments; Peptides; Protease Inhibitors; Protein Precursors; Pyrroles; Swine; Valine | 2002 |
Enhanced secretion of glucagon-like peptide 1 by biguanide compounds.
Topics: Animals; Biguanides; Buformin; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; Peptide Fragments; Phenformin; Protease Inhibitors; Protein Precursors; Pyrroles; Rats; Rats, Inbred F344; Valine | 2002 |
cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
Topics: Animals; ATP-Binding Cassette Transporters; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoquinolines; Mice; Mice, Knockout; Peptide Fragments; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Kinase C; Pyrroles; Receptors, Drug; Reference Values; Sulfonamides; Sulfonylurea Receptors | 2002 |
Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition.
Topics: Actins; Aging; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Insulin; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Proglucagon; Protease Inhibitors; Protein Precursors; Pyrroles; Valine | 2003 |
Differential regional metabolism of glucagon in anesthetized pigs.
Topics: Anesthesia; Animals; Carotid Arteries; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Gastrointestinal Agents; Glucagon; In Vitro Techniques; Pyrroles; Swine; Valine; Veins | 2003 |
[Optimizing the managment of patients with diabetes mellitus: selected clinical trials from the 2004 Congress of the American Diabetes Association].
Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Exenatide; Glucagon; Glucagon-Like Peptide 1; Heptanoic Acids; Humans; Islets of Langerhans Transplantation; Peptide Fragments; Peptides; Protein Precursors; Pyrroles; Venoms | 2004 |
Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptid
Topics: Animals; Dipeptidyl Peptidase 4; Female; Gastric Inhibitory Polypeptide; Gastrin-Releasing Peptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Secretion; Mice; Mice, Inbred C57BL; Nerve Growth Factors; Neuropeptides; Neurotransmitter Agents; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Protease Inhibitors; Protein Precursors; Pyrroles; Valine | 2005 |
GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.
Topics: Animals; Binding, Competitive; Blood Glucose; Chlorocebus aethiops; COS Cells; Cyclic AMP; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon; Humans; Insulin; Male; Pancreas; Peptide Fragments; Perfusion; Pyrroles; Rats; Rats, Wistar; Receptors, Gastrointestinal Hormone; Swine; Valine | 2006 |
Effects of hypoxia on glucose, insulin, glucagon, and modulation by corticotropin-releasing factor receptor type 1 in the rat.
Topics: Altitude; Animals; Blood Glucose; Body Weight; Corticosterone; Eating; Glucagon; Hypoxia; Insulin; Leptin; Liver Glycogen; Male; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone | 2007 |
Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones.
Topics: Alanine; Asparagine; Cell Membrane; Curcumin; Cyclic AMP; Drug Design; Glucagon; Green Fluorescent Proteins; HEK293 Cells; Humans; Molecular Chaperones; Mutation; Pancreatic Neoplasms; Protein Transport; Pyridines; Pyrroles; Receptors, Glucagon; Serine; Thapsigargin | 2012 |
Glucagon Increases Beating Rate but Not Contractility in Rat Right Atrium. Comparison with Isoproterenol.
Topics: Animals; Atrial Function, Right; Calcium Signaling; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Glucagon; Heart Atria; Heart Rate; Isoproterenol; Isoquinolines; Male; Myocardial Contraction; Myocardium; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2015 |